# Histopathological Characterization and Whole Exome Sequencing of Ectopic Thyroid: Fetal Architecture in a Functional Ectopic Gland from Adult Patient

Authors: Rosalinda Yasato Camargo; Cristina Takami Kanamura; Celso Ubirajara Friguglietti; Célia Regina Nogueira; Sonia Iorcansky; Alfio José Tincani; Ana Karina Bezerra; Ester Brust; Fernanda Christtanini Koyama; Anamaria Aranha Camargo; Fernanda Orpinelli R. Rego; Pedro Alexandre Favoretto Galante; Geraldo Medeiros-Neto; Ileana Gabriela Sanchez Rubio
Journal: International Journal of Endocrinology
 (2018)

---

## Abstract

Ectopic thyroid results from a migration defect of the developing gland during embryogenesis causing congenital hypothyroidism. But it has also been detected in asymptomatic individuals. This study aimed to investigate the histopathological, functional, and genetic features of human ectopic thyroids. Six samples were histologically examined, and the expression of the specific thyroid proteins was assessed by immunohistochemistry. Two samples were submitted to whole exome sequencing. An oropharynx sample showed immature fetal architecture tissue with clusters or cords of oval thyrocytes and small follicles; one sample exhibited a normal thyroid pattern while four showed colloid goiter. All ectopic thyroids expressed the specific thyroid genes and T4 at similar locations to those observed in normal thyroid. No somatic mutations associated with ectopic thyroid were found. This is the first immature thyroid fetal tissue observed in an ectopic thyroid due to the arrest of structural differentiation early in the colloid stage of development that proved able to synthesize thyroid hormone but not to respond to TSH. Despite the ability of all ectopic thyroids to synthetize specific thyroid proteins and T4, at some point in life, it may be insufficient to support body growth leading to hypothyroidism, as observed in some of the patients.


---

## Body

## 1. Introduction

The thyroid gland is a bilobar gland composed of two endocrine cells, namely, the thyroid follicular cells (TFCs) that produce the thyroid hormones T3 and T4 and the parafollicular cells that secrete calcitonin. TFCs are derived from the thyroid primordium, or thyroid anlage, that originates from a thickening of the endodermal epithelium in the foregut at the base of the prospective tongue. This structure develops the thyroid diverticulum that proliferates, invades the surrounding mesenchyme, and migrates through the anterior midline of the neck. During migration, the primitive thyroid acquires a bilobed structure while the thyroglossal duct, the initial connection to the primitive pharyngeal floor, loses its lumen and turns into disconnected fragments. When the developing thyroid reaches its final position at the base of the neck in front of the trachea, the fusion of the ultimobranchial bodies takes place to give rise to C cells. Finally, folliculogenesis occurs concomitantly with differentiation of thyroid progenitor cells into functional thyroid follicular cells, expressing specific thyroid genes such as TSH receptor (TSHR), Na/I symporter (NIS), and thyroglobulin (TG) [1–3].In mouse models, normal embryogenesis of the thyroid was shown to be controlled by a well-integrated regulatory network of transcription factors [4, 5]. During the formation of the thyroid anlage (specification phase), the expression of thyroid transcription factors TITF1, PAX8, FOXE1, and HEX1 can be observed. FOXE1 is believed to be required for migration of the mouse thyroid primordium after detachment of the bud [6], and survival of the thyroid primordium depends on the expression of FOXE1 and PAX8 [4].Ectopic thyroid is a rare malformation that results from a migration defect of the developing gland during embryogenesis [1]. The glands can be found at any point along the path of migration, from the foramen cecum to the mediastinum, and also in distal subdiaphragmatic areas. However, the most frequent site is at the base of the tongue or lingual thyroid [7]. Ectopia is the most common form of thyroid dysgenesis (TD) and congenital hypothyroidism [8, 9] but has also been detected in asymptomatic individuals or as a cause of hypothyroidism, dysphonia, dysphagia, cough, snoring, or sleep apnea and coexisting with a normally located thyroid [10–12] [13, 14].The pathogenesis of ectopic thyroid, and the fact that some ectopic patients remain euthyroid throughout life, has not yet been elucidated. Few studies have characterized the expression of important thyroid proteins [10, 14]. In addition, mutations in genes FOXE1, PAX8, TSHR, NKX2.1, or NKX2.5 associated with TD were identified in only 2-3% of TD cases [15]. Recently, with whole exome sequencing (WES), a powerful tool for investigating genetic causes of human diseases, novel genes were identified in TD cases [16, 17].Thus, the aim of the present study was to investigate the histopathological and functional characteristics of human ectopic thyroid tissues through the expression of T4, specific thyroid proteins TG, NIS, TSHR, and thyroid transcription factors NKX2.1 and PAX8 by immunohistochemistry and to identify potential pathogenic mutations with expanded whole exome sequencing.


## 2. Material and Methods

### 2.1. Samples

Paraffin blocks of four human ectopic thyroid samples were retrospectively collected from patients who underwent thyroid resection, and two flash-frozen tissue samples removed due to symptoms (sample 4) or suspicious cytology for papillary thyroid lesion (patient 2) were also included in the study. The control sample was taken from archived paraffin blocks of the normal thyroid. The study protocol was approved by the local Research Ethics Committees (HC 893/01 and CEP 1078/11).


### 2.2. Patients

All patients were born before the establishment of the mandatory Neonatal Screening Program in Brazil, except for patient 5. Clinicopathologic information on the ectopic patients was obtained from medical records.Patient 1 is a 34-year-old female with an oropharyngeal ectopic thyroid mass detected at 7 years of age. The patient was never treated with levothyroxine (LT4) and had two cesarean deliveries. Preoperative thyroid hormonal status was TSH: 11.19 mIU/L (ref. 0.5–4.2 mIU/L), and total T4: 2.48 μg/dL (ref. 5.3–12.6 μg/dL) (to convert to nmol/L, multiply by 12.87). Patient 2 is a 46-year-old female with ectopic thyroid located at the hyoid bone. The patient had been treated with LT4 (100 μg/day) for hypothyroidism for the last 30 years. Goiter was diagnosed 4 years before surgery. Patient 3 is a 7-year-old euthyroid girl. Lingual thyroid was detected at 5 years of age when investigating swallowing and sleeping difficulties. The patient was never treated with LT4. Patient 4 is a 38-year-old male with lingual thyroid causing excessive snoring. The patient was never treated with LT4, and preoperative thyroid hormonal status was FT4: 0.6 ng/dL (ref. 0.6–1.54 ng/dL) (to convert to pmol/L, multiply by 12.87), TSH: 46.7 mIU/L (ref. 0.5–4.2 mIU/L), and negative anti-TPO and anti-Tg. Patient 5 is a one-month-old girl with midline defect and lingual thyroid, diagnosed after surgery for suspected lingual tumor. Neonatal test after surgery indicated TSH > 200 mIU/L. Patient 6 is a 13-year-old girl with a neck nodule noted at birth that grew during childhood development. At 11 years of age, lingual thyroid was diagnosed and hypothyroidism confirmed with serum TSH: 11.42 mIU/L, FT4: 0.73 ng/dL (ref. 0.897–1.794 ng/dL), and negative anti-TPO. Levothyroxine was prescribed, but the patient showed poor compliance.


### 2.3. Immunohistochemistry

Threeμm thick sections of formalin-fixed and paraffin-embedded tissue samples from the six patients (samples 1–6) were first stained with hematoxylin/eosin for histological observation and then submitted to immunohistochemical procedures. Antigen retrieval was performed in 10 mM citrate buffer/pH 6.0 in a pressure cooker for three minutes, and endogenous peroxidase was inactivated in 6% hydrogen peroxide solution in an incubation step. The antibodies used in this study were monoclonal anti-thyroid peroxidase (TPO) (MoAb47, 1 : 500, DakoCytomation, Glostrup, Denmark), monoclonal anti-sodium-iodide symporter (NIS) (FP5A, 1 : 200, Mayo Clinic, USA), monoclonal anti-TTF1 (NKX2.1) (8G7G3/1, 1 : 500, Cell Marque, Rocklin, USA), monoclonal anti-thyroid-stimulating hormone receptor (TSHR) (4C1/E1/G8, 1 : 200, NeoMarkers, Fremont, USA), polyclonal anti-PAX8 (rabbit, 1 : 500, Cell Marque), polyclonal anti-thyroglobulin (rabbit, 1 : 400.000; DakoCytomation), and polyclonal anti-thyroxine (T4) (rabbit, 1 : 1.000; Cloud-Clone Corp., Houston, USA). Tissue sections were incubated overnight with the primary antibodies, and amplifications were obtained by peroxidase-conjugated polymer (Ultravision TL015-HDS, Thermo Fisher Scientific, Fremont, USA) and then revealed by diaminobenzidine/hydrogen peroxide substrate chromogen. Images were acquired using a Leica TCS SP8 microscope. The samples were examined by two of the authors.


### 2.4. Whole Exome Sequencing and Analysis

Total DNA from ectopic tissue from patients 2 and 4 was used to prepare the DNA library with Agilent SureSelectXT reagent kit (Agilent Technologies®, Santa Clara, USA), and the whole exome and UTR regions were sequenced in Illumina NextSeq 500 platform (Illumina® Inc., San Diego, USA) with a calculated coverage average of 140x per sample. Sequenced reads were aligned to a reference genome (GRCh37/hg19) using Burrows-Wheeler Alignment (BWA), and calling was performed with Genome Analysis Toolkit (GATK). Single nucleic variants and small insertions-deletions were annotated with ANNOVAR [18]. Data were filtered with 12 sample controls of Brazilian familial thyroid cancer tissues, variants with low-quality score, and common variants (MAF > 1%), and neutral variants were eliminated. Predictions of deleterious effect were evaluated using online bioinformatics tools: SIFT, PolyPhen-2, mutationassessor, fathmm, Condel, MutationTaster, and PROVEAN [19–21].


## 2.1. Samples

Paraffin blocks of four human ectopic thyroid samples were retrospectively collected from patients who underwent thyroid resection, and two flash-frozen tissue samples removed due to symptoms (sample 4) or suspicious cytology for papillary thyroid lesion (patient 2) were also included in the study. The control sample was taken from archived paraffin blocks of the normal thyroid. The study protocol was approved by the local Research Ethics Committees (HC 893/01 and CEP 1078/11).


## 2.2. Patients

All patients were born before the establishment of the mandatory Neonatal Screening Program in Brazil, except for patient 5. Clinicopathologic information on the ectopic patients was obtained from medical records.Patient 1 is a 34-year-old female with an oropharyngeal ectopic thyroid mass detected at 7 years of age. The patient was never treated with levothyroxine (LT4) and had two cesarean deliveries. Preoperative thyroid hormonal status was TSH: 11.19 mIU/L (ref. 0.5–4.2 mIU/L), and total T4: 2.48 μg/dL (ref. 5.3–12.6 μg/dL) (to convert to nmol/L, multiply by 12.87). Patient 2 is a 46-year-old female with ectopic thyroid located at the hyoid bone. The patient had been treated with LT4 (100 μg/day) for hypothyroidism for the last 30 years. Goiter was diagnosed 4 years before surgery. Patient 3 is a 7-year-old euthyroid girl. Lingual thyroid was detected at 5 years of age when investigating swallowing and sleeping difficulties. The patient was never treated with LT4. Patient 4 is a 38-year-old male with lingual thyroid causing excessive snoring. The patient was never treated with LT4, and preoperative thyroid hormonal status was FT4: 0.6 ng/dL (ref. 0.6–1.54 ng/dL) (to convert to pmol/L, multiply by 12.87), TSH: 46.7 mIU/L (ref. 0.5–4.2 mIU/L), and negative anti-TPO and anti-Tg. Patient 5 is a one-month-old girl with midline defect and lingual thyroid, diagnosed after surgery for suspected lingual tumor. Neonatal test after surgery indicated TSH > 200 mIU/L. Patient 6 is a 13-year-old girl with a neck nodule noted at birth that grew during childhood development. At 11 years of age, lingual thyroid was diagnosed and hypothyroidism confirmed with serum TSH: 11.42 mIU/L, FT4: 0.73 ng/dL (ref. 0.897–1.794 ng/dL), and negative anti-TPO. Levothyroxine was prescribed, but the patient showed poor compliance.


## 2.3. Immunohistochemistry

Threeμm thick sections of formalin-fixed and paraffin-embedded tissue samples from the six patients (samples 1–6) were first stained with hematoxylin/eosin for histological observation and then submitted to immunohistochemical procedures. Antigen retrieval was performed in 10 mM citrate buffer/pH 6.0 in a pressure cooker for three minutes, and endogenous peroxidase was inactivated in 6% hydrogen peroxide solution in an incubation step. The antibodies used in this study were monoclonal anti-thyroid peroxidase (TPO) (MoAb47, 1 : 500, DakoCytomation, Glostrup, Denmark), monoclonal anti-sodium-iodide symporter (NIS) (FP5A, 1 : 200, Mayo Clinic, USA), monoclonal anti-TTF1 (NKX2.1) (8G7G3/1, 1 : 500, Cell Marque, Rocklin, USA), monoclonal anti-thyroid-stimulating hormone receptor (TSHR) (4C1/E1/G8, 1 : 200, NeoMarkers, Fremont, USA), polyclonal anti-PAX8 (rabbit, 1 : 500, Cell Marque), polyclonal anti-thyroglobulin (rabbit, 1 : 400.000; DakoCytomation), and polyclonal anti-thyroxine (T4) (rabbit, 1 : 1.000; Cloud-Clone Corp., Houston, USA). Tissue sections were incubated overnight with the primary antibodies, and amplifications were obtained by peroxidase-conjugated polymer (Ultravision TL015-HDS, Thermo Fisher Scientific, Fremont, USA) and then revealed by diaminobenzidine/hydrogen peroxide substrate chromogen. Images were acquired using a Leica TCS SP8 microscope. The samples were examined by two of the authors.


## 2.4. Whole Exome Sequencing and Analysis

Total DNA from ectopic tissue from patients 2 and 4 was used to prepare the DNA library with Agilent SureSelectXT reagent kit (Agilent Technologies®, Santa Clara, USA), and the whole exome and UTR regions were sequenced in Illumina NextSeq 500 platform (Illumina® Inc., San Diego, USA) with a calculated coverage average of 140x per sample. Sequenced reads were aligned to a reference genome (GRCh37/hg19) using Burrows-Wheeler Alignment (BWA), and calling was performed with Genome Analysis Toolkit (GATK). Single nucleic variants and small insertions-deletions were annotated with ANNOVAR [18]. Data were filtered with 12 sample controls of Brazilian familial thyroid cancer tissues, variants with low-quality score, and common variants (MAF > 1%), and neutral variants were eliminated. Predictions of deleterious effect were evaluated using online bioinformatics tools: SIFT, PolyPhen-2, mutationassessor, fathmm, Condel, MutationTaster, and PROVEAN [19–21].


## 3. Results

### 3.1. Histopathology of Ectopic Thyroids

Fetal thyroid architecture was observed in sample 1 which exhibited isolated epithelial oval cells that were unpolarized or arranged in clusters and cords and primitive small follicles lined by cuboidal cells with a small lumen, some of them with colloid embedded in stroma (Figures1 and 2). Small areas of the section with normal-sized follicles were also observed.Figure 1
Hematoxylin/eosin staining (a) (10x) and immunohistochemistry expression of specific thyroid genes in ectopic thyroid tissue sample 1 showing fetal architecture with clusters, cords and isolated epithelial oval cells, small follicles lined by cuboidal cells, and small areas of normal-sized follicles (b–h) (40x). TG: intense diffuse expression in the lumen of follicles and in cytoplasm of microfollicles and isolated thyrocytes (b). TPO: intense immunostaining in the apical membrane of micro- and normal-sized follicles; cytoplasmic TPO was observed in follicular cells and isolated thyrocytes (c). TSHR: scattered staining in the cytoplasm of thyrocytes (d). NKX2.1: strong diffuse nuclear immunostaining observed in most nuclei (e). PAX8: moderate or intense expression observed in around 80% of nuclei (f). NIS: diffuse cytoplasmic staining observed (g). Thyroxine (T4): diffuse and intense expression observed in the colloid of micro- and normal-sized follicles (h).
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)Figure 2
Immunohistochemistry expression of specific thyroid genes in ectopic and normal thyroid tissue. (A) Representative images of samples 2, 3, 4, and 6 showing goiter; (B) sample 5 exhibiting normal thyroid pattern; and (C) normal thyroid sample. TG: intense diffuse TG expression in the lumen of all follicles of the ectopic and normal samples; weak or negative cytoplasmic staining in cell follicles (a–c). TPO: intense immunostaining in the cytoplasm of thyrocytes and in the apical membrane of the follicles of ectopic samples examined, similar to the normal thyroid sample (d–f). TSHR: scattered staining in the cytoplasm of thyrocytes in ectopic and normal samples (g–i); magnified representative image showing basolateral membrane staining in some cells. NKX2.1: strong diffuse nuclear immunostaining was observed in most of the nuclei of the ectopic and normal thyroid tissues (j–l), except for sample 2, showing 10% positive nuclei. PAX8: moderate expression observed in around 80% of nuclei of normal and ectopic thyroid tissues (m–o) with focal areas of low nuclear expression in the ectopic samples. In sample 2, only 20% of positive nuclei were positive and scattered cytoplasmic expression was also observed. NIS: cytoplasmic staining was observed in all samples (p–r), and basolateral membrane positivity was observed in up to 10% of cells of samples 3, 4, and 5 (p, q). Normal samples had a similar pattern of 20% positivity in the basolateral membrane and cytoplasmic staining (r). Thyroxine (T4): moderate or intense diffuse expression in follicular colloid was observed, although some follicles showed low immunostaining, similar to the normal thyroid (s–u). Magnification at 40x except for the images of a, c, s, and u at 20x.Histopathological examination of samples 2, 3, 4, and 6 revealed colloid goiter with highly enlarged follicles lined by flattened epithelial cells (Figure2(A)). Focal areas (10–25%) composed of normal-sized follicles with cuboidal cells were also detected in these samples. Sample 5 showed normal thyroid tissue (Figure 2(B)).


### 3.2. Immunohistochemistry Expression

TG expression was intense and diffuse in the lumen of all follicles of the samples under investigation, even in microfollicles from tissue with fetal architecture (sample 1). Cytoplasmic TG staining was weak or negative in the normal-sized follicles and also in the macrofollicles of the ectopic samples, similarly to normal thyroid sample. However, strong cytoplasmic staining was observed in isolated thyrocytes and microfollicles from the fetal thyroid tissue (sample 1) (Figures1(a), 1(b), and 2, a–c).TPO staining was strong and diffuse within the cytoplasm of thyrocytes and was also observed in the apical membrane of all follicles of the ectopic samples examined, similar to normal thyroid tissue. Only cytoplasmic TPO was observed in isolated thyrocytes from fetal thyroid tissue (sample 1) (Figures1(c) and 2, d–f).TSHR expression was intense and scattered within the cytoplasm of thyrocytes of the ectopic samples, akin to a normal sample (Figures1(d) and 2, g–i).NKX2.1 diffuse immunostaining was strong in the majority of the nuclei of the ectopic thyroid samples, except for sample 2 which had approximately 10% low positive nuclei and scattered cytoplasmic expression. Low expression was observed in most of the nuclei of normal thyroid (Figures1(e) and 2, j–l).PAX8 moderate to intense diffuse expression was observed for all ectopic samples in approximately 70–80% of follicular cell nuclei, except for sample 2 which had a low expression in around 20% of nuclei and scattered cytoplasmic expression. Expression in normal thyroid tissue was low in most of the nuclei (Figures1(f) and 2, m–o).NIS was positive in the basolateral membrane in up to 10% of the cells of ectopic samples 3, 4, and 5. Cytoplasmic staining was observed in all samples. Normal thyroid sample had a similar pattern of 20% positivity in the basolateral membrane and cytoplasmic staining (Figures1(g) and 2, p–r).T4 expression was diffuse and intense in colloid of micro- and normal-sized follicles from the fetal thyroid sample (Figure1(h)). In the other ectopic samples, the colloid T4 expression was moderate or intense, although some follicles showed low or negative immunostaining, similarly to normal thyroid (Figure 2, s–u).


### 3.3. Whole Exome Sequencing

After filtering the sequencing data, 3501 and 3287 variants (indel or SNVs) were identified in samples 2 and 4, respectively. The approaches to select deleterious mutations were (a) identification of common variants, (b) investigation of homozygous alterations (161 and 165, resp.) due to a possible recessive pattern of inheritance, (c) the candidate gene approach along with a list of 190 genes related to development and thyroid function (Table1) [22–34] because no family members were available, and (d) identification of variants in the 5’UTRs of genes with binding motifs for FOXE1 (Table 2) [35, 36] and PAX8 (Table 3) [37] because these transcription factors are expressed from the early stages of thyroid embryogenesis. None of the selected variants were predicted deleterious by the specific programs. Thus, this analysis did not identify somatic mutations in the sequenced regions that could correlate with the disease.Table 1
Candidate genes related to development and thyroid function (gene symbol) [22–34].
ABCA13
DIO2
FOXE3
KDR
SFRP1
ACP2
DKK3
FOXQ1
KLF4
SFRP2
ACTA1
DMD
FRS2
KPNA4
SFRS2
AKT1
DTX4
FRS2A
LAMA4
SHH
AKT3
DUOX1
FRZB
LEFTY1
SIX1
ANKRD36B
DUOX2
FXR1
LHX3
SLC26A4
ARHGEF6
DUOXA1
FZD1
LHX4
SLC5A5
ASPM
DUOXA2
FZD3
LMO3
SMAD3
ATP2A1
DUSP6
FZD4
LRP8
SMAD5
BCL2L1
EDN1
GATA5
LYZ
SMAD9
BCL2L12
EDN3
GJA1
MKI67
SMOC2
BGN
EEF1A2
GLIS3
MKRN1
SNX1
BMP4
EFNB2
GNG5
MS4A6A
SOX17
C9orf70
EGFR
GPNMB
MTHFD2
SOX9
CCND1
EGR1
GSTT1
MUC1
SPRED1
CDC42EP4
EMP3
HADHA
MYBPC1
TAL1
CDH16
ENO3
HAND2
MYL2
TAZ
CDH2
EVC2
HES1
NAV1
TBX1
CEBPB
EYA1
HESX1
NKX2.1
TCAP
CECR1
FAU
HHEX
NKX2.5
TCF4
CFC1B
FBLN1
HLA-DQA1
NLK
TEF
CGA
FGF10
HLA-DQB1
PABPC1
TG
CHGA
FGF12
HOXA2
PAX2
TGFB2
CHORDC1
FGF2
HOXA3
PAX8
THRA
CKM
FGF3
HOXA5
PBX4
THRB
CLDN5
FGF8
HOXB3
PCSK2
THRSP
CNTN6
FGFR1
HOXD3
PITX2
TNFAIP2
COL1A1
FGFR2
HSPA1B
PKNOX1
TNFRSF21
COL3A1
FGL2
IGHG4
PLCXD1
TNNC2
CPEB4
FLJ11127
IGJ
PLEKHA3
TPO
CREB1
FLJ32115
IGSF1
PLXND1
TRA
CTGF
FMR1
INHBB
POLD4
TRH
CTNNAL1
FN1
INSL3
PRKCE
TSHb
CXCL12
FOS
ISL1
PROP1
TSHR
CXCR4
FOSB
ISL2
RARRES1
TWSG1
CYBB
FOXA1
IYD
RASD1
TXNIP
CYBRD1
FOXA2
JAG1
RNASE6
TYROBP
DIO1
FOXE1
JAG3
ROBO4
VEGFATable 2
Target genes of the transcription factor FOXE1 (gene symbol) [35, 36].
ADAMTS9
CRIP2
ENGASE
IL23A
RT1-DA
AHCY
CTGF
ERO1LB
KRT20
S100A4
AMIGO3
DDIT3
ETV5
MANF
SDF2L1
ANKRD37
DERL3
FGF18
MFSD2
SEC23B
ATMIN
DNAJB11
FOLR1
NR4A2
SEL1L
BCAM
DNAJB9
GGCT
NUPR1
SLIT1
BET1
DNAJC3
GMPPB
PDIA4
TM4SF1
CASP4
DUOX2
HSP90B1
PRIMA1
TMEM140
CDH1
DUSP5
HSPA5
PRSS8
TMEM66
COQ10B
DYNLRB2
HYOU1
RIL
ZFAND2A
CRELD2
ELOVL2
IGF2BP2
RIOK3Table 3
Target genes of the transcription factor PAX8 (gene symbol) [37].
ACOT2
CFD
GCSH
LACTB
RASSF2
ACY1
CITED2
GJA4
LRP8
RSAD2
ADAMTS9
CRYAB
GSTP1
LRRC58
RUNX2
ALCAM
CTGF
HACD4
NFKB1
SLC26A7
ANKRD9
CXCL1
HSD17B1
NR3C2
SMIM22
ARHGAP22
DGAT2
IGFBP5
NRIP3
SPARC
BHLHE40
EGR1
IGFBP7
NUP107
STS
BRAF
EIF4E
IRGQ
OPRK1
TAZ
CAMK1G
ENPP1
JUN
OSTALPHA
TEKT4
CAMKK2
F10
KCNJ15
PBLD
TG
CD47
FAM13A
KCNJ16
POMT1
TMEM140
CDA
FGFR2
KCNK1
PRR5L
TRIB1
CDH16
FOXE1
KRT14
RAB17
WBP2
CDH16
GALK2
KRT7
RASL10A
WNT4


## 3.1. Histopathology of Ectopic Thyroids

Fetal thyroid architecture was observed in sample 1 which exhibited isolated epithelial oval cells that were unpolarized or arranged in clusters and cords and primitive small follicles lined by cuboidal cells with a small lumen, some of them with colloid embedded in stroma (Figures1 and 2). Small areas of the section with normal-sized follicles were also observed.Figure 1
Hematoxylin/eosin staining (a) (10x) and immunohistochemistry expression of specific thyroid genes in ectopic thyroid tissue sample 1 showing fetal architecture with clusters, cords and isolated epithelial oval cells, small follicles lined by cuboidal cells, and small areas of normal-sized follicles (b–h) (40x). TG: intense diffuse expression in the lumen of follicles and in cytoplasm of microfollicles and isolated thyrocytes (b). TPO: intense immunostaining in the apical membrane of micro- and normal-sized follicles; cytoplasmic TPO was observed in follicular cells and isolated thyrocytes (c). TSHR: scattered staining in the cytoplasm of thyrocytes (d). NKX2.1: strong diffuse nuclear immunostaining observed in most nuclei (e). PAX8: moderate or intense expression observed in around 80% of nuclei (f). NIS: diffuse cytoplasmic staining observed (g). Thyroxine (T4): diffuse and intense expression observed in the colloid of micro- and normal-sized follicles (h).
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)Figure 2
Immunohistochemistry expression of specific thyroid genes in ectopic and normal thyroid tissue. (A) Representative images of samples 2, 3, 4, and 6 showing goiter; (B) sample 5 exhibiting normal thyroid pattern; and (C) normal thyroid sample. TG: intense diffuse TG expression in the lumen of all follicles of the ectopic and normal samples; weak or negative cytoplasmic staining in cell follicles (a–c). TPO: intense immunostaining in the cytoplasm of thyrocytes and in the apical membrane of the follicles of ectopic samples examined, similar to the normal thyroid sample (d–f). TSHR: scattered staining in the cytoplasm of thyrocytes in ectopic and normal samples (g–i); magnified representative image showing basolateral membrane staining in some cells. NKX2.1: strong diffuse nuclear immunostaining was observed in most of the nuclei of the ectopic and normal thyroid tissues (j–l), except for sample 2, showing 10% positive nuclei. PAX8: moderate expression observed in around 80% of nuclei of normal and ectopic thyroid tissues (m–o) with focal areas of low nuclear expression in the ectopic samples. In sample 2, only 20% of positive nuclei were positive and scattered cytoplasmic expression was also observed. NIS: cytoplasmic staining was observed in all samples (p–r), and basolateral membrane positivity was observed in up to 10% of cells of samples 3, 4, and 5 (p, q). Normal samples had a similar pattern of 20% positivity in the basolateral membrane and cytoplasmic staining (r). Thyroxine (T4): moderate or intense diffuse expression in follicular colloid was observed, although some follicles showed low immunostaining, similar to the normal thyroid (s–u). Magnification at 40x except for the images of a, c, s, and u at 20x.Histopathological examination of samples 2, 3, 4, and 6 revealed colloid goiter with highly enlarged follicles lined by flattened epithelial cells (Figure2(A)). Focal areas (10–25%) composed of normal-sized follicles with cuboidal cells were also detected in these samples. Sample 5 showed normal thyroid tissue (Figure 2(B)).


## 3.2. Immunohistochemistry Expression

TG expression was intense and diffuse in the lumen of all follicles of the samples under investigation, even in microfollicles from tissue with fetal architecture (sample 1). Cytoplasmic TG staining was weak or negative in the normal-sized follicles and also in the macrofollicles of the ectopic samples, similarly to normal thyroid sample. However, strong cytoplasmic staining was observed in isolated thyrocytes and microfollicles from the fetal thyroid tissue (sample 1) (Figures1(a), 1(b), and 2, a–c).TPO staining was strong and diffuse within the cytoplasm of thyrocytes and was also observed in the apical membrane of all follicles of the ectopic samples examined, similar to normal thyroid tissue. Only cytoplasmic TPO was observed in isolated thyrocytes from fetal thyroid tissue (sample 1) (Figures1(c) and 2, d–f).TSHR expression was intense and scattered within the cytoplasm of thyrocytes of the ectopic samples, akin to a normal sample (Figures1(d) and 2, g–i).NKX2.1 diffuse immunostaining was strong in the majority of the nuclei of the ectopic thyroid samples, except for sample 2 which had approximately 10% low positive nuclei and scattered cytoplasmic expression. Low expression was observed in most of the nuclei of normal thyroid (Figures1(e) and 2, j–l).PAX8 moderate to intense diffuse expression was observed for all ectopic samples in approximately 70–80% of follicular cell nuclei, except for sample 2 which had a low expression in around 20% of nuclei and scattered cytoplasmic expression. Expression in normal thyroid tissue was low in most of the nuclei (Figures1(f) and 2, m–o).NIS was positive in the basolateral membrane in up to 10% of the cells of ectopic samples 3, 4, and 5. Cytoplasmic staining was observed in all samples. Normal thyroid sample had a similar pattern of 20% positivity in the basolateral membrane and cytoplasmic staining (Figures1(g) and 2, p–r).T4 expression was diffuse and intense in colloid of micro- and normal-sized follicles from the fetal thyroid sample (Figure1(h)). In the other ectopic samples, the colloid T4 expression was moderate or intense, although some follicles showed low or negative immunostaining, similarly to normal thyroid (Figure 2, s–u).


## 3.3. Whole Exome Sequencing

After filtering the sequencing data, 3501 and 3287 variants (indel or SNVs) were identified in samples 2 and 4, respectively. The approaches to select deleterious mutations were (a) identification of common variants, (b) investigation of homozygous alterations (161 and 165, resp.) due to a possible recessive pattern of inheritance, (c) the candidate gene approach along with a list of 190 genes related to development and thyroid function (Table1) [22–34] because no family members were available, and (d) identification of variants in the 5’UTRs of genes with binding motifs for FOXE1 (Table 2) [35, 36] and PAX8 (Table 3) [37] because these transcription factors are expressed from the early stages of thyroid embryogenesis. None of the selected variants were predicted deleterious by the specific programs. Thus, this analysis did not identify somatic mutations in the sequenced regions that could correlate with the disease.Table 1
Candidate genes related to development and thyroid function (gene symbol) [22–34].
ABCA13
DIO2
FOXE3
KDR
SFRP1
ACP2
DKK3
FOXQ1
KLF4
SFRP2
ACTA1
DMD
FRS2
KPNA4
SFRS2
AKT1
DTX4
FRS2A
LAMA4
SHH
AKT3
DUOX1
FRZB
LEFTY1
SIX1
ANKRD36B
DUOX2
FXR1
LHX3
SLC26A4
ARHGEF6
DUOXA1
FZD1
LHX4
SLC5A5
ASPM
DUOXA2
FZD3
LMO3
SMAD3
ATP2A1
DUSP6
FZD4
LRP8
SMAD5
BCL2L1
EDN1
GATA5
LYZ
SMAD9
BCL2L12
EDN3
GJA1
MKI67
SMOC2
BGN
EEF1A2
GLIS3
MKRN1
SNX1
BMP4
EFNB2
GNG5
MS4A6A
SOX17
C9orf70
EGFR
GPNMB
MTHFD2
SOX9
CCND1
EGR1
GSTT1
MUC1
SPRED1
CDC42EP4
EMP3
HADHA
MYBPC1
TAL1
CDH16
ENO3
HAND2
MYL2
TAZ
CDH2
EVC2
HES1
NAV1
TBX1
CEBPB
EYA1
HESX1
NKX2.1
TCAP
CECR1
FAU
HHEX
NKX2.5
TCF4
CFC1B
FBLN1
HLA-DQA1
NLK
TEF
CGA
FGF10
HLA-DQB1
PABPC1
TG
CHGA
FGF12
HOXA2
PAX2
TGFB2
CHORDC1
FGF2
HOXA3
PAX8
THRA
CKM
FGF3
HOXA5
PBX4
THRB
CLDN5
FGF8
HOXB3
PCSK2
THRSP
CNTN6
FGFR1
HOXD3
PITX2
TNFAIP2
COL1A1
FGFR2
HSPA1B
PKNOX1
TNFRSF21
COL3A1
FGL2
IGHG4
PLCXD1
TNNC2
CPEB4
FLJ11127
IGJ
PLEKHA3
TPO
CREB1
FLJ32115
IGSF1
PLXND1
TRA
CTGF
FMR1
INHBB
POLD4
TRH
CTNNAL1
FN1
INSL3
PRKCE
TSHb
CXCL12
FOS
ISL1
PROP1
TSHR
CXCR4
FOSB
ISL2
RARRES1
TWSG1
CYBB
FOXA1
IYD
RASD1
TXNIP
CYBRD1
FOXA2
JAG1
RNASE6
TYROBP
DIO1
FOXE1
JAG3
ROBO4
VEGFATable 2
Target genes of the transcription factor FOXE1 (gene symbol) [35, 36].
ADAMTS9
CRIP2
ENGASE
IL23A
RT1-DA
AHCY
CTGF
ERO1LB
KRT20
S100A4
AMIGO3
DDIT3
ETV5
MANF
SDF2L1
ANKRD37
DERL3
FGF18
MFSD2
SEC23B
ATMIN
DNAJB11
FOLR1
NR4A2
SEL1L
BCAM
DNAJB9
GGCT
NUPR1
SLIT1
BET1
DNAJC3
GMPPB
PDIA4
TM4SF1
CASP4
DUOX2
HSP90B1
PRIMA1
TMEM140
CDH1
DUSP5
HSPA5
PRSS8
TMEM66
COQ10B
DYNLRB2
HYOU1
RIL
ZFAND2A
CRELD2
ELOVL2
IGF2BP2
RIOK3Table 3
Target genes of the transcription factor PAX8 (gene symbol) [37].
ACOT2
CFD
GCSH
LACTB
RASSF2
ACY1
CITED2
GJA4
LRP8
RSAD2
ADAMTS9
CRYAB
GSTP1
LRRC58
RUNX2
ALCAM
CTGF
HACD4
NFKB1
SLC26A7
ANKRD9
CXCL1
HSD17B1
NR3C2
SMIM22
ARHGAP22
DGAT2
IGFBP5
NRIP3
SPARC
BHLHE40
EGR1
IGFBP7
NUP107
STS
BRAF
EIF4E
IRGQ
OPRK1
TAZ
CAMK1G
ENPP1
JUN
OSTALPHA
TEKT4
CAMKK2
F10
KCNJ15
PBLD
TG
CD47
FAM13A
KCNJ16
POMT1
TMEM140
CDA
FGFR2
KCNK1
PRR5L
TRIB1
CDH16
FOXE1
KRT14
RAB17
WBP2
CDH16
GALK2
KRT7
RASL10A
WNT4


## 4. Discussion

Ectopic thyroid has a prevalence of 1 : 100,000–300,000 individuals and 1 : 4000–8000 among patients with thyroid disease [7] and is more frequent among females (65–80%) [38] while age at diagnosis ranges from the neonatal period to adult life. In terms of thyroid function, patients can present hypothyroid, euthyroidism, and, more rarely, hyperthyroidism [7, 14, 39].In the present study, we investigated six ectopic thyroid samples: four were lingual thyroids, one was located at the oropharynx, and another at the hyoid bone. The histology of previously reported ectopic thyroid cases have shown a normal thyroid follicular pattern [10, 40] and a predisposition for similar abnormalities to those observed in normal-positioned glands, such as follicular adenoma, colloid goiter, and others [14, 41–45]. In the present study, the histopathological examination of the ectopic thyroid tissue from one adult patient (sample 1) disclosed an immature fetal architecture pattern characterized by the presence of clusters and cords of epithelial oval unpolarized cells, primitive follicles, and small follicles embedded in stroma with small areas of normal-sized follicles [27, 46]. Thyroid tissue with fetal-like appearance was previously identified in an apparently unaffected mother of congenital hypothyroid children associated with a heterozygous PAX8 mutation [47]. Although no mutational investigation was performed, the immunohistochemistry examination showed strong nuclear PAX8 expression in around 80% of the cells of this tissue. It remains to be investigated whether this is a functional protein. The other ectopic samples exhibited normal thyroid features (sample 5) or colloid goiter patterns (samples 2, 3, 4, and 6).All ectopic samples expressed T4 and the specific thyroid proteins TPO, TG, TSHR, PAX8, NKX2.1, and NIS, although focal follicles, tissue areas, or thyrocytes within follicles failed to express several of these proteins (data not shown). A heterogeneous expression pattern was also observed in normal thyroid tissues and has been related to morphological features and the ability of thyrocytes and follicles to concentrate iodine [48, 49]. Sample 2 had low nuclear expression of PAX8 and NKX2.1 and scattered cytoplasmic immunostaining; however, no somatic mutations were detected by WES. Both genes have been linked to thyroid development [3] and are expressed in the thyroid anlage when migration initiates [50], and mutations have been associated with few TD cases [51]. On the other hand, in ectopia, high PAX8 expression was associated to the activation state of the gland [22], and high expression of NKX2.1 was related to abnormal embryogenesis [14]. Thus, further studies assessing the significance of the observed data are warranted.The location of the specific thyroid proteins was similar to that observed in normal thyroid [22, 52]. The cytoplasmic TSHR staining may have been due to the use of an antibody against the extracellular domain of this protein, as previously described [53]. Likewise, the cytoplasmic NIS localization in all the samples and the membrane immunostaining in four of them was in accordance with previous reports [27, 46, 54].Previous transcriptome analysis showed no difference in the expression of specific thyroid genes between ectopic and normal thyroid tissue when corrected for TSH levels [22]. Despite the protein expression data not being corrected for TSH levels, our results confirm the expression and the appropriate localization of these proteins in ectopia, including T4. More interestingly, they confirm that primitive follicles in sample 1 were able to synthetize T4, asserting the functional status of the gland, although it may have been unable to respond to TSH.The clinical data of the patients suggest that the ectopic thyroids have been able to synthetize adequate amounts of thyroid hormone at least early in the patient’s life. Nevertheless, the amount of secreted thyroid hormone might not be sufficient to meet the body’s needs during growth, promoting hypothyroidism, given that hormone requirement is based on body weight [55]. The low hormone production may be a consequence of the small size of the ectopic glands, possibly due to the migration defect, and of a limitation in TSH-induced growth [14].Human thyroid morphogenesis begins at 22 days of pregnancy and is largely complete when reaching its final position in front of the trachea at 7 gestational weeks (GW) (48 days of pregnancy). At this point, the thyroid is composed of undifferentiated thyrocytes and expresses strong PAX8 and weak NKX2.1 and FOXE1 [2, 50]. Subsequently, the structural and functional differentiations of the thyroid ensue, accompanied by precisely timed expression of the specific thyroid genes and can be divided into three stages. First is the precolloid stage (7 to 10 GW), with a large number of cords or clusters of undifferentiated thyrocytes expressing PAX8, FOXE1, NKX2.1, and cytoplasmic TG and TSHR, while expression of NIS and TPO is not observed. Second is the beginning of the colloid stage (10 to 11 GW) with developing small follicles with polarizing thyrocytes that express TPO in the apical membrane, TSHR in the basolateral membrane, NIS in cytoplasm, and TG in follicular lumen and culminates with T4 synthesis. The third stage is the follicular growth stage (from 12 GW forth) with the basolateral membrane expression of NIS [27, 46]. Thus, our data allow us to hypothesize that at least three different impairments in thyroid development may have led to ectopic thyroid. In patient 1, a premature arrest of migration (33–48 days of gestation) may have led to positioning of the gland at the oropharyngeal level [1] with a subsequent arrest of the structural differentiation during the early colloid stage [1, 46], resulting in a nonhomogeneous fetal thyroid tissue pattern able to synthetize T4. Second, in patient 2, the migration of the developing gland may have also stopped before reaching its final position, resulting in the thyroid positioned at the hyoid bone, along with complete structural and functional differentiation. Third, the thyroid primordium may not have been able to detach from the pharyngeal floor and migrate, promoting a lingual thyroid with a complete structural and functional differentiation as observed in patients 3, 4, 5, and 6. Thus, the arrest of this process may have occurred earlier, at 26 days of gestation, when migration begins [1].To assess potential somatic genetic causes of TD in protein-coding regions and 5’UTRs, expanded exome analysis was performed in samples 2 and 4. Unfortunately the poor quality of the DNA from paraffin tissues from the other samples did not allow performing the genetic analysis. Despite the different exome-sequencing analysis approaches, no relevant somatic mutations were identified in the sequenced regions. A similar result was also obtained in a previous study that investigated somatic mutations in monozygotic twins discordant to TD [56]. On the other hand, WES identified novel missense mutations in the BOREALIN gene in a consanguineous family with TD [16] and DUOX2 mutations in the N-terminal domain that may play a role in thyroid development in sporadic TD cases [17], confirming the genetic heterogeneity of this pathology. Furthermore, the involvement of other genetic mechanisms may be also considered. Novel copy number variations (CNVs), not described in the healthy population, were identified in 8.75% of 80 TD patients [54, 56]. No differences in the CpG island methylation of promoter regions were observed between normal eutopic and ectopic thyroid tissues [22, 57]. Thus, the cause of TD could be associated with molecular alterations in other regions of the genoma or with polygenic or other epigenetic alterations, or it could be purely stochastic.In conclusion, no somatic mutations in the sequenced regions were associated with ectopic thyroid. This is the first description of fetal histopathological architecture in an adult ectopic thyroid due to the arrest of structural differentiation of the developing gland along with the arrest of migration that proved able to synthesize thyroid hormone but not to respond to TSH. We showed the ability of the ectopic thyroids to express specific thyroid genes and T4, despite the migratory and histological differentiation defects, as well as the ability to synthesize the thyroid hormone for at least some period of the patient’s life.



---

*Source: 4682876-2018-02-08.xml*